209 related articles for article (PubMed ID: 31950225)
1. CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γ
Capuano C; Pighi C; Maggio R; Battella S; Morrone S; Palmieri G; Santoni A; Klein C; Galandrini R
Cancer Immunol Immunother; 2020 Apr; 69(4):501-512. PubMed ID: 31950225
[TBL] [Abstract][Full Text] [Related]
2. Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.
Capuano C; Pighi C; Molfetta R; Paolini R; Battella S; Palmieri G; Giannini G; Belardinilli F; Santoni A; Galandrini R
Oncoimmunology; 2017; 6(3):e1290037. PubMed ID: 28405525
[TBL] [Abstract][Full Text] [Related]
3. miR-155 regulates IFN-γ production in natural killer cells.
Trotta R; Chen L; Ciarlariello D; Josyula S; Mao C; Costinean S; Yu L; Butchar JP; Tridandapani S; Croce CM; Caligiuri MA
Blood; 2012 Apr; 119(15):3478-85. PubMed ID: 22378844
[TBL] [Abstract][Full Text] [Related]
4. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
Capuano C; Romanelli M; Pighi C; Cimino G; Rago A; Molfetta R; Paolini R; Santoni A; Galandrini R
Cancer Res; 2015 Oct; 75(19):4097-108. PubMed ID: 26229120
[TBL] [Abstract][Full Text] [Related]
6. The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo.
Palazzo A; Herter S; Grosmaire L; Jones R; Frey CR; Limani F; Bacac M; Umana P; Oldham RJ; Marshall MJE; Cox KL; Turaj AH; Cragg MS; Klein C; Carter MJ; Tannheimer S
J Immunol; 2018 Apr; 200(7):2304-2312. PubMed ID: 29453281
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Targeting Anti-CD20 Antibodies Mediate
Capuano C; Battella S; Pighi C; Franchitti L; Turriziani O; Morrone S; Santoni A; Galandrini R; Palmieri G
Front Immunol; 2018; 9():1031. PubMed ID: 29867997
[TBL] [Abstract][Full Text] [Related]
8. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
Kawauchi K; Ihjima K; Yamada O
J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Göckeritz E; Kerwien S; Baumann M; Wigger M; Vondey V; Neumann L; Landwehr T; Wendtner CM; Klein C; Liu N; Hallek M; Frenzel LP; Krause G
Int J Cancer; 2015 Nov; 137(9):2234-42. PubMed ID: 25912635
[TBL] [Abstract][Full Text] [Related]
10. Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
Kondadasula SV; Roda JM; Parihar R; Yu J; Lehman A; Caligiuri MA; Tridandapani S; Burry RW; Carson WE
Blood; 2008 Apr; 111(8):4173-83. PubMed ID: 18174382
[TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.
Srivastava S; Pelloso D; Feng H; Voiles L; Lewis D; Haskova Z; Whitacre M; Trulli S; Chen YJ; Toso J; Jonak ZL; Chang HC; Robertson MJ
Cancer Immunol Immunother; 2013 Jun; 62(6):1073-82. PubMed ID: 23604103
[TBL] [Abstract][Full Text] [Related]
12. Screening for Active Compounds Targeting Human Natural Killer Cell Activation Identifying Daphnetin as an Enhancer for IFN-γ Production and Direct Cytotoxicity.
Yao B; Yang Q; Yang Y; Li Y; Peng H; Wu S; Wang L; Zhang S; Huang M; Wang E; Xiong P; Luo T; Li L; Jia S; Deng Y; Deng Y
Front Immunol; 2021; 12():680611. PubMed ID: 34956168
[TBL] [Abstract][Full Text] [Related]
13. The PI3K∂-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression.
Rohrbacher L; Brauchle B; Ogrinc Wagner A; von Bergwelt-Baildon M; Bücklein VL; Subklewe M
Front Immunol; 2021; 12():608625. PubMed ID: 33790890
[TBL] [Abstract][Full Text] [Related]
14. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding.
Aramburu J; Azzoni L; Rao A; Perussia B
J Exp Med; 1995 Sep; 182(3):801-10. PubMed ID: 7650486
[TBL] [Abstract][Full Text] [Related]
15. Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors.
Hassenrück F; Knödgen E; Göckeritz E; Midda SH; Vondey V; Neumann L; Herter S; Klein C; Hallek M; Krause G
Biomed Res Int; 2018; 2018():1023490. PubMed ID: 29750146
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human IL-15 trans-presentation by B leukemic cells from chronic lymphocytic leukemia induces autologous NK cell proliferation leading to improved anti-CD20 immunotherapy.
Laprevotte E; Voisin G; Ysebaert L; Klein C; Daugrois C; Laurent G; Fournie JJ; Quillet-Mary A
J Immunol; 2013 Oct; 191(7):3634-40. PubMed ID: 23997218
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan carried by tumor-derived microvesicles induces IL-10 production in classical (CD14
Lenart M; Rutkowska-Zapala M; Baj-Krzyworzeka M; Szatanek R; Węglarczyk K; Smallie T; Ziegler-Heitbrock L; Zembala M; Siedlar M
Immunobiology; 2017 Jan; 222(1):1-10. PubMed ID: 26210045
[TBL] [Abstract][Full Text] [Related]
18. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
Le Garff-Tavernier M; Decocq J; de Romeuf C; Parizot C; Dutertre CA; Chapiro E; Davi F; Debré P; Prost JF; Teillaud JL; Merle-Beral H; Vieillard V
Leukemia; 2011 Jan; 25(1):101-9. PubMed ID: 20975664
[TBL] [Abstract][Full Text] [Related]
19. Effects of PI3K Inhibition on Afucosylated Antibody-Driven FcγRIIIa Events and Phospho-S6 Activity in NK Cells.
Romeo V; Gierke S; Edgar KA; Liu SD
J Immunol; 2019 Jul; 203(1):137-147. PubMed ID: 31092639
[TBL] [Abstract][Full Text] [Related]
20. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.
Rosario M; Liu B; Kong L; Collins LI; Schneider SE; Chen X; Han K; Jeng EK; Rhode PR; Leong JW; Schappe T; Jewell BA; Keppel CR; Shah K; Hess B; Romee R; Piwnica-Worms DR; Cashen AF; Bartlett NL; Wong HC; Fehniger TA
Clin Cancer Res; 2016 Feb; 22(3):596-608. PubMed ID: 26423796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
